A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1
Bryan R. Haugen(University of Colorado Cancer Center), E. Chester Ridgway(University of Colorado Denver), Kathryn E. Graham(Oregon Health & Science University), Gilbert H. Daniels(Harvard University), Markus Luster(Klinik und Poliklinik für Nuklearmedizin), Paul W. Ladenson(Johns Hopkins University), Martin Schlumberger(Institut Gustave Roussy), Kevin McEllin, Harry R. Maxon(University of Cincinnati), David S. Cooper(Johns Hopkins University), Terry F. Davies(University of Minnesota System), Christoph Reiners(Klinik und Poliklinik für Nuklearmedizin), Lewis E. Braverman(Repatriation General Hospital), Carole A. Spencer(University of Southern California), D. Vaughn Becker(Southern Polytechnic State University), Furio Pacini(University of Siena), Steven I. Sherman(The University of Texas MD Anderson Cancer Center), Ernest L. Mazzaferri(The Ohio State University), Leslie J. DeGroot(University of Chicago), Bruce D. Weintraub(University of Maryland, Baltimore), Monica C. Skarulis(National Institutes of Health), Mary H. Samuels(Oregon Health & Science University), Ralph R. Cavalieri(United States Department of Veterans Affairs), Douglas S. Ross(Albert Einstein College of Medicine)
Cited by 564
Related Papers
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
|Thyroid|2009|6.7k
The Colorado Thyroid Disease Prevalence Study
|Archives of Internal Medicine|2000|2.8k
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
|Thyroid|2016|2.8k
Subclinical Thyroid Disease
|JAMA|2004|1.8k
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2016|921